NBC News reports:
Pfizer-BioNTech requested Tuesday that the Food and Drug Administration clear its Covid-19 vaccine for use in children ages 5 to 11. The FDA is expected to take at least several weeks to analyze data collected in a trial that included more than 2,000 children before it would grant emergency use authorization.
While the Pfizer vaccine has been available for Americans 12 and older since May, millions of elementary school-age children are still vulnerable. Pfizer said its two-dose Covid vaccine has shown to be safe, while prompting a “well tolerated” and “robust” antibody response among the younger, targeted group.
Read the full article.
JUST IN: Pfizer-BioNTech requests that the FDA clear its Covid-19 vaccine for use in children ages 5 to 11. https://t.co/Ob6JkrKlaf
— NBC News (@NBCNews) September 28, 2021